ReviewFrontiers in allergy2025

Predictors of response to omalizumab and relapse in chronic spontaneous Urticaria: a narrative review focusing on parameters available in routine clinical practice.

Laura Mateu-Arrom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.